{
    "clinical_study": {
        "@rank": "144477", 
        "acronym": "MAKP", 
        "arm_group": {
            "arm_group_label": "Patient", 
            "arm_group_type": "Other", 
            "description": "congenital cystic adenomatoid malformations"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to identify genetic abnormalities and molecular pathways associated\n      with the occurrence of CCAM."
        }, 
        "brief_title": "Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Congenital Cystic Adenomatoid Malformation (CCAM)", 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Cystic Adenomatoid Malformation of Lung, Congenital"
            ]
        }, 
        "detailed_description": {
            "textblock": "Congenital lung malformations are rare diseases, characterized by the coexistence in the\n      same individual of normal lung and localized lung malformation. Among these malformations,\n      congenital cystic adenomatoid malformations (CCAM) represent the most important group, with\n      an estimated incidence between 1/11 000 and 1/35 000 births. The precise mechanisms leading\n      to these lung malformations remain poorly understood. This project aims to identify key\n      genetic and/or molecular mechanisms associated with the occurrence of CCAM. CCAMs are\n      collected during postnatal surgical resection. Parental agreement is required. A\n      standardised histologic description of malformations is performed for each sample. Normal\n      lung tissue at the periphery of the malformation is considered as control. Malformations\n      will be analyzed in a systematic way by proteome and transcriptome, after laser\n      microdissection. Somatic genetic abnormalities will also systematically be sought."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children < 8 years\n\n          -  Thoracic surgery for congenital lung malformation\n\n          -  Parental written consent\n\n        Exclusion Criteria:\n\n          -  Children > 8 years\n\n          -  Previous infection of the malformation\n\n          -  Parental rebutal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "8 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732185", 
            "org_study_id": "P100510"
        }, 
        "intervention": {
            "arm_group_label": "Patient", 
            "description": "Blood and histological samples will be done at day of the inclusion.", 
            "intervention_name": "Patient", 
            "intervention_type": "Genetic"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Congenital lung malformation", 
            "Congenital Cystic Adenomatoid Malformation", 
            "Cystic lung disease"
        ], 
        "lastchanged_date": "August 2, 2013", 
        "location": {
            "contact": {
                "email": "christophe.delacourt@nck.aphp.fr", 
                "last_name": "Christophe Delacourt, MD, PhD", 
                "phone": "+ 33 1 44 49 49 55"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "Necker-Enfants Malades Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations", 
        "overall_contact": {
            "email": "christophe.delacourt@nck.aphp.fr", 
            "last_name": "Christophe Delacourt, MD, PhD", 
            "phone": "+ 33 1 44 49 49 55"
        }, 
        "overall_contact_backup": {
            "email": "laurence.lecomte@nck.aphp.fr", 
            "last_name": "Laurence Lecomte, PhD", 
            "phone": "+33 1 71 19 64 94"
        }, 
        "overall_official": {
            "affiliation": "Necker-Enfants Malades Hospital", 
            "last_name": "Christophe Delacourt, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Transcriptomic analysis", 
            "measure": "mRNA expression", 
            "safety_issue": "No", 
            "time_frame": "at Day 0"
        }, 
        "reference": {
            "PMID": "22726873", 
            "citation": "Kotecha S, Barbato A, Bush A, Claus F, Davenport M, Delacourt C, Deprest J, Eber E, Frenckner B, Greenough A, Nicholson AG, Ant\u00f3n-Pacheco JL, Midulla F. Antenatal and postnatal management of congenital cystic adenomatoid malformation. Paediatr Respir Rev. 2012 Sep;13(3):162-70; quiz 170-1. doi: 10.1016/j.prrv.2012.01.002. Epub 2012 Apr 25. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732185"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Proteomic expression", 
                "measure": "Protein expression", 
                "safety_issue": "No", 
                "time_frame": "at Day 0"
            }, 
            {
                "description": "CGH array", 
                "measure": "Somatic genetic abnormalities", 
                "safety_issue": "No", 
                "time_frame": "at Day 0"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}